In conclusion, our preclinical studies using multiple in vitro cell lines and in vivo mouse models as well as human clinical studies all suggest that ATP-P2RX6-Ca2+ −p-ERK1/2-MMP9 axis facilitate RCC migration and invasion. This evidence concerns the gene MAPK3 and renal cell carcinoma.